NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro

Regulatory Peptides

Volumn 120, Issue 1-3, 2004, Pages 107-112

  Hastings, Jacqueline A ^a   Morris, Margaret J ^b   Lambert, Gavin ^a   Lambert, Elisabeth ^a   Esler, Murray ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Dihydroxyphenylglycol (DHPG); High performance liquid chromatography (HPLC); Hypothalamus; In vitro superfusion; Medulla

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR; NORADRENALIN; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; DRUG DERIVATIVE; NEUROPEPTIDE Y; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y, LEU(31) PRO(34); NEUROPEPTIDE Y, LEU(31)-PRO(34)-; NEUROPEPTIDE Y-Y1 RECEPTOR;

ANIMAL TISSUE; APPETITE; ARTICLE; CONTROLLED STUDY; COULOMETRY; HYPOTHALAMUS; IN VITRO STUDY; MALE; MEDULLA OBLONGATA; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PRISM; RAT; REDUCTION KINETICS; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; ANIMAL; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; APPETITE; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MALE; METHOXYHYDROXYPHENYLGLYCOL; NEUROPEPTIDE Y; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; TIME FACTORS;

EID: 2642560200     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.02.015     Document Type: Article

References (32)

1. Beck B. Neuropeptides and obesity. Nutrition. 16:2000;916-923
2. Mertens I.L., Van Gaal L.F. Promising new approaches to the management of obesity. Drugs. 60:2000;1-9
3. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671
4. Dryden S.H., Frankish H., Wang Q., Williams G. Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur. J. Clin. Invest. 24:1994;293-308
5. Bischoff A., Michel M.C. Emerging functions for neuropeptide Y5 receptors. Trends Pharmacol. Sci. 20:1999;104-106
6. Dumont Y., Fournier A., Quirion R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J. Neurosci. 18:1998;5565-5574
7. 1 antagonist, J-115814. Mol. Pharmacol. 59:2001;501-505
8. 1 receptor in rat central nervous system. Brain Res. 889:2001;23-37
9. Flood J.F., Hernandez E.N., Morley J.E. Modulation of memory processing by neuropeptide Y. Brain Res. 421:1987;280-290
10. Esteban J., Chover A.J., Sanchez P.A., Mico J.A., Gilbert-Rahola J. Central administration of neuropeptide y induces hypothermia in mice. Possible interaction with central noradrenergic systems. Life Sci. 45:1989;2395-2400
11. Heilig M. Neuropeptide Y in relation to behavior and psychiatric disorders: some animal and clinical observations. Colmers W.F., Wahlestedt C. The Biology of Neuropeptide Y and Related peptides. 1993;511-555 Humana Press, Totowa, NJ
12. Morris M.J., Hastings J.A., Pavia J.M. Central interactions between noradrenaline and neuropeptide Y in the rat: implications for blood pressure control. Clin. Exp. Hypertens. 19:1997;619-630
13. 34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat. Brain. Res. 750:1997;301-304
14. 1 receptors exert opposite effects on corticotropin releasing factor and noradrenaline overflow from the rat hypothalamus in vitro. Brain Res. 890:2001;32-37
15. Glowinski J., Iversen L. Regional studies of catecholamines in the rat brain: 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. Biochem. Pharmacol. 15:1966;977-987
16. Eisenhofer G., Goldstein D.S., Stull R., Keiser H.R., Sunderland T., Murphy D.L., et al. Simultaneous liquid-chromatographic determination of 3, 4-dihydroxyphenylglycol, catecholamines, and 3, 4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin. Chem. 32:1986;2030-2033
17. 2- noradrenergic receptors in the paraventricular nucleus mediate feeding induced by norepinephrine and clonidine. Eur. J. Pharmacol. 115:1985;11-19
18. Leibowitz S.F. Brain monoamines and peptides: role in the control of eating behavior. Fed. Proc. 45:1986;1396-1403
19. Jhanwar-Uniyal M., Darwish M., Levin B.E., Leibowitz S.F. Alterations in catecholamine levels and turnover in discrete brain regions after food deprivation. Pharmacol. Biochem. Behav. 26:1987;271-275
20. Sawchenko P.E., Swanson L.W., Grzanna R., Howe P.R.C., Bloom S.R., Polak J.M. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J. Comp. Neurol. 241:1985;138-153
21. Stanley B.G., Leibowitz S.F. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 35:1984;2635-2642
22. Beck B., Burlet A., Nicolas J.P., Burlet C. Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: implications in feeding and sexual behaviors. Physiol. Behav. 47:1990;449-453
23. Amendt K., Czachurski J., Dembowsky K., Seller H. Bulbospinal projections to the inermediolateral cell column: a neuroanatomical study. J. Auton. Nerv Syst. 1:1979;103-117
24. McAllen R.M., May C.N., Campos R.R. The supply of vasomotor drive to individual classes of sympathetic neuron. Clin. Exp. Hypertens. 19:1997;607-618
25. 2-adrenergic receptors in the hypothalamus of spontaneously hypertensive rats. Jpn. Heart J. 33:1992;229-238
26. De Potter W.P., Kurzawa R., Miserez B., Coen E.P. Evidence against differential release of noradrenaline, neuropeptide Y, and dopamine-β- hydroxylase from adrenergic nerves in the isolated perfused sheep spleen. Synapse. 19:1995;67-76
27. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171
28. Bitran M., Tapia W., Eugenín E., Orio P., Boric M.P. Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: role of receptor subtype and nitric oxide. Brain Res. 851:1999;87-93
29. Eisenhofer G., Goldstein D.S., Ropchak T.G., Nguyen H.Q., Keiser H.R., et al. Source and physiological significance of plasma 3, 4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol. J. Auton. Nerv. Syst. 24:1988;1-14
30. Esler M., Jennings G., Lambert G., Meredith I., Horner M., Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol. Rev. 70:1990;963-985
31. Gershon M.D., Sherman D.L., Pintar J.E. Type-specific localization of monoamine oxidase in the enteric nervous system: relationship to 5-hydroxytryptamine, neuropeptides, and sympathetic nerves. J. Comp. Neurol. 301:1990;191-213
32. Schwartz T.W., Fuhlendorff J., Langeland N., Thøgerson H., Jørgenson J.Ch., Sheik S.P. Mutt V., Hokfelt T., Fuxe K. Neuropeptide Y, 14th Nobel Symposium. 1989;534-541 Raven, New York